A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
NCT03058562
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Tourette Syndrome
Chronic Motor Tic Disorder
Interventions
DRUG:
ABX-1431
DRUG:
Placebo Comparator
DRUG:
ABX-1431
Sponsor
Abide Therapeutics